Is Pfizer on track to launch its next Lipitor -- this time in the weight-loss market?

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes ...

Pfizer's once-a-month weight loss shot shows early promise, but years from approval

Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years before it receives regulatory approval ...

Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

Pharmaceutical giants Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are still the two titans of the weight loss drug market, to be sure. Lilly sold $13.5 billion worth of GLP ...
Nasdaq

Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units

(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...
Forbes

Weight Loss Pills Intensify Obesity Drug Race—But Here’s Why Experts Say Injections Aren’t Going Anywhere

Competition in the race to crack the lucrative weight loss drug market is heating up as rivals like Roche, Eli Lilly, Novo Nordisk and Pfizer develop oral medications that help people shed weight ...

One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
MM&M

Pfizer’s birth control injection has a new safety label, reflecting potential brain tumors

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...